Alexion reports $165M profit for 2Q

ALEXION PHARMACEUTICALS REPORTED a $165 million profit in the second quarter of 2017. /COURTESY ALEXION
ALEXION PHARMACEUTICALS REPORTED a $165 million profit in the second quarter of 2017. /COURTESY ALEXION
NEW HAVEN, Conn. - Alexion Pharmaceuticals Inc., a company that focuses on developing therapies for patients with devastating and rare diseases, reported a $165 million profit for the second quarter of 2017, a 37.5 percent increase year over year. Net earnings were 73 cents per diluted share. The report said the numbers reflected a benefit…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -